Pictet Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
17,860
+1,041
| +6% | +$18.6K | ﹤0.01% | 1598 |
|
|
2025
Q1 | $302K | Buy |
16,819
+1,900
| +13% | +$34.1K | ﹤0.01% | 1616 |
|
|
2024
Q4 | $445K | Buy |
14,919
+2,468
| +20% | +$73.5K | ﹤0.01% | 1429 |
|
|
2024
Q3 | $195K | Hold |
12,451
| – | – | ﹤0.01% | 1826 |
|
|
2024
Q2 | $213K | Hold |
12,451
| – | – | ﹤0.01% | 1722 |
|
|
2024
Q1 | $195K | Hold |
12,451
| – | – | ﹤0.01% | 1777 |
|
|
2023
Q4 | $186K | Hold |
12,451
| – | – | ﹤0.01% | 1773 |
|
|
2023
Q3 | $201K | Buy |
+12,451
| New | +$201K | ﹤0.01% | 1687 |
|